The largest database of trusted experimental protocols
Sourced in United States, Macao

The NIH3T3 is a fibroblast cell line derived from the embryonic mouse NIH/3T3 cell line. It is a widely used in vitro model system for various biological studies. The core function of the NIH3T3 cell line is to serve as a standardized cell culture model for research purposes.

Automatically generated - may contain errors

63 protocols using nih3t3

1

Cell Culture and Transfection Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney cells (293FT) and mouse embryonic fibroblast cells (NIH3T3) were obtained from Invitrogen and American Type Culture Collection (ATCC) respectively. Both cell lines were cultured in Dulbecco modified Eagle medium plus 10% FBS (Gibco, Invitrogen). Transfection of 293FT and NIH3T3 cells were performed using LipofectamineTM LTX reagent (Invitrogen) following the manufacturer’s protocol.
+ Open protocol
+ Expand
2

Culturing Metastatic Breast Cancer and Fibroblast Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The metastatic murine 4T1-luc breast cancer cells and the fibroblast NIH 3T3 cells were purchased from the American Type Culture Collection. The 4T1-luc cells were maintained in Roswell Park Memorial Institute 1640 (Gibco, Invitrogen) medium with 10% fetal bovine serum (FBS), penicillin (100 U ml−1), streptomycin (100 U ml−1), and 1% L-glutamine. The NIH3T3 cells were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Invitrogen) with 10% FBS, penicillin (100 U ml−1), streptomycin (100 U ml−1), and 1% L-glutamine.
+ Open protocol
+ Expand
3

Characterization of CDK12 Mutant Neuroblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human neuroblastoma (NB) cells (Kelly, IMR-32, IMR-5, LAN-1, LAN-5, NGP, SK-N-AS, SH-SY5Y, CHLA-20, CHLA-15, and SK-N-FI) were obtained from the Children’s Oncology Group cell line bank and genotyped at the DFCI Core Facility. The cell lines were authenticated through STR analyses. The Kelly E9R NB cell line harbors a single point mutation in CDK12 at the cysteine 1039 covalent binding site of THZ531. Specifically, this mutation was acquired spontaneously in Kelly NB cells upon exposure to escalating doses of CDK12 inhibitor, E9 over the course of few months as previously reported20 (link). Human lung (IMR-90) and skin fibroblasts (BJ) were kindly provided by Dr. Richard Gregory (Boston Children’s Hospital). NIH3T3 cells were purchased from the American Type Culture Collection (ATCC). NB cells were grown in RPMI (Invitrogen) supplemented with 10% FBS and 1% penicillin/streptomycin (Invitrogen). IMR-90, BJ, and NIH3T3 cells were grown in DMEM (Invitrogen) supplemented with 10% FBS and 1% penicillin/streptomycin. All cell lines were routinely tested for mycoplasma.
+ Open protocol
+ Expand
4

Generation and Culture of Mouse Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
B6 fibroblasts were generated as previously described.83 (link) Qa-1b expressing L cells were generated as previously described.28 (link) NIH 3T3 (ATC#CRL-1658) and RAW 264.7 mouse macrophages (ATCC TIB-71) were purchased from ATCC. QFL hybridomas (BEko8Z cells) were established in the Shastri lab as described.28 (link) B6 fibroblasts and splenocytes were cultured in complete RPMI (cRPMI) with 10% FBS (Invitrogen, Carlsbad CA), 100 U/ml Penicillin/Streptomycin (Invitrogen), 2mM L-Glutamine, and 50 μM 2-ME. NIH 3T3 and RAW 264.7 cells were cultured in complete DMEM with 10% FBS (Invitrogen, Carlsbad CA) and 100 U/ml Penicillin/Streptomycin (Invitrogen). All cell lines were maintained at 37°C, 5% CO2, and 95% humidity.
+ Open protocol
+ Expand
5

Cell Line Authentication and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T and NIH3T3 cells (NIH3T3 CRL-1658) cells were obtained from the American Type Culture Collection (ATCC)(Manassas, VA). These cells were authenticated and tested for mycoplasma contamination by ATCC at the time of purchase. L cells stably expressing Jagged1 (Jag1) or Delta-like 1 (Dll1) were a gift of Dr. Gerry Weinmater (UCLA). MS5 cells stably expressing Delta-like 4 (Dll4) were a gift from Dr. Stephen Blacklow. HEK293T, NIH3T3, L cells, and MS5 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)(Invitrogen) supplemented with 10% bovine calf serum.
+ Open protocol
+ Expand
6

Cell Line Characterization and Mouse Xenograft

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse embryonic fibroblast cell lines NIH3T3 and the human lung fibroblasts MRC-5 were purchased from UNC Tissue Culture Facility. The human bladder transitional cell line UMUC3 was provided by Dr. William Kim. The human pancreatic cancer BXPC3-Luc2 was purchased from PerkinElmer (Waltham, MA). UMUC3 and NIH3T3 were maintained in Dulbecco’s Modified Eagle’s Media (Invitrogen, CA), supplemented with 10% fetal bovine serum (FBS) (Sigma, MO) or 10% bovine calf serum (Sigma, MO). BXPC3-Luc2 cells were cultured in full RPMI-1640 medium (Invitrogen, CA), while MRC-5 were cultured in full αMEM (Invitrogen, CA). Cell lines were authenticated by Dr. William Kim’s group and UNC Tissue Culture Facility using the Short Tandem Repeat (STR) profiling method. Female nude mice 6–8 weeks-old were obtained from and raised by the University of North Carolina animal facility. All animal handling procedures were approved by the University of North Carolina at Chapel Hill’s Institutional Animal Care and Use Committee. Primary and secondary antibodies used for Western blot (WB), flow cytometry (flow cyt), immunofluorescence staining (IF), and immunohistochemistry (IHC) staining are listed in Table S1.
+ Open protocol
+ Expand
7

Cell Line Authentication and Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T and NIH3T3 cells (NIH3T3 CRL-1658) cells were obtained from the American Type Culture Collection (ATCC)(Manassas, VA). These cells were authenticated and tested for mycoplasma contamination by ATCC at the time of purchase. L cells stably expressing Jagged1 (Jag1) or Delta-like 1 (Dll1) were a gift of Dr. Gerry Weinmater (UCLA). MS5 cells stably expressing Delta-like 4 (Dll4) were a gift from Dr. Stephen Blacklow. HEK293T, NIH3T3, L cells, and MS5 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)(Invitrogen) supplemented with 10% bovine calf serum.
+ Open protocol
+ Expand
8

Cell Culture of Common Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The fibroblast NIH 3T3, human blood B lymphocytes RAMOS (RA1), melanoma B16F10, and metastatic murine 4T1 breast cancer cell lines were purchased from the American Type Culture Collection. The NIH 3T3 cells were cultured in complete Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Invitrogen) with 10% fetal bovine serum (FBS), penicillin (100 U mL−1), streptomycin (100 U mL−1), and 1% l-glutamine. The RA1 and 4T1 cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 (Gibco, Invitrogen) medium with 10% FBS, penicillin (100 U mL−1), streptomycin (100 U mL−1), and 1% l-glutamine.
+ Open protocol
+ Expand
9

Cell Line Cultivation and Clinical Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines: The PDAC cell lines Capan-1, Capan-2, MIA-Paca2, Panc-1, and Aspc-1, the embryonic kidney cell line HEK293, and NIH3T3 were purchased from American Type Culture Collection (ATCC, Rockville, Maryland). The PDAC cell lines PK-59 and KLM-1 were provided by the Cell Resource Center for Biomedical Research, Tohoku University (Sendai, Japan). All cells were cultured in appropriate media: RPMI-1640 (Sigma, St. Louis, MO) for Capan-1, Capan-2, Aspc-1, KLM-1, and PK-59 and Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA) for MIApaca-2, Panc-1, and NIH3T3. Each medium was supplemented with 10% fetal bovine serum (Cansera) and 1% antibiotic/antimycotic solution (Sigma). Cells were maintained at 37°C in an atmosphere of humidified air with 5% CO2. Clinical samples (pancreatic cancer and normal pancreatic duct) were obtained from surgical specimens that were resected at Hokkaido University Hospital. Informed consent was obtained from patients, and the study was approved by the institutional review board of Hokkaido University Hospital (ID; 014-0224). Normal tissue sections were purchased from Biochain (Hayward, CA, USA).
+ Open protocol
+ Expand
10

Transient Transfection of SHSY5Y and NIH3T3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SHSY5Y and NIH3T3 cells were purchased from the American Type Culture Collection (Manassas, VA) and maintained in 5 % CO2 at 37 °C in Dulbecco’s modified Eagle’s medium (DMEM) containing 10 % fetal calf serum (FCS), 100 U/ml penicillin, and 100 μg/ml streptomycin in 10 cm plates. After 70 to 80 % confluence, cells were rinsed with 1× PBS. Following trypsinization and mechanical dissociation, cells were subcultured into 24-well plates and incubated at 37 °C for 2 days preceding transfection. Transfection was done after the cells reached 70 to 80 % confluence. pBDNF constructs, pGL3-Basic, or pGL3-SV40 vector was transiently transfected into SHSY5Y and NIH3T3 cells using Lipofectamine 2000 (Invitrogen). Briefly, for each transfection, 2.0 μg of DNA and 5 μl of Lipofectamine were first diluted in OPTI-MEM (GibcoBRL), mixed gently, and incubated at room temperature for 5 min. Cells were rinsed once with PBS and OPTI-MEM was added before incubation with the DNA/Lipofectamine. The pRL-SV40 Renilla luciferase vector (50 ng) was co-transfected in all experiments. Cells were allowed to incubate at 37 °C and the media was replaced after 12 h by fresh DMEM. Cells were harvested 48 h after the start of transfection.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!